About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of neoadjuvant pembrolizumab, new data revealed.
Taking 160 milligrams of aspirin a day cuts the risk of cancer recurrence in half among colon cancer patients with a mutation in their PI3K genes, researchers reported at the 2025 American Society of ...
A recent American Cancer Society report highlights the increasing incidence of colorectal cancer in young adults. Understanding risk factors and recognizing symptoms are crucial for early detection ...
Results that may be inaccessible to you are currently showing.